Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Akari Therapeutics

    NASDAQ: AKTX · Real-Time Price · USD
    1.28
    -0.00 (-0.16%)
    At close: Jun 06, 2025, 3:49 PM
    1.27
    -0.78%
    After-hours: Jun 06, 2025, 04:04 PM EDT

    Akari Therapeutics Statistics

    Share Statistics

    Akari Therapeutics has 16.09K shares outstanding. The number of shares has increased by 306427.39% in one year.

    Shares Outstanding

    n/a
    		 16.09K

    Shares Change (YoY)

    n/a
    		 306427.39%

    Shares Change (QoQ)

    n/a
    		 225888.37%

    Owned by Institutions (%)

    n/a
    		 0.26%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 2,041

    FTD / Avg. Volume

    n/a
    		 8.47%

    Short Selling Information

    The latest short interest is 118.29K, so 0.37% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 118.29K

    Short % of Shares Out

    n/a
    		 0.37%

    Short % of Float

    n/a
    		 0.57%

    Short Ratio (days to cover)

    n/a
    		 6.45

    Valuation Ratios

    PE Ratio

    n/a
    		 0

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0

    PB Ratio

    n/a
    		 0

    P/FCF Ratio

    n/a
    		 0

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Akari Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.15, with a Debt / Equity ratio of 0.15.

    Current Ratio

    n/a
    		 0.15

    Quick Ratio

    n/a
    		 0.15

    Debt / Equity

    n/a
    		 0.15

    Debt / EBITDA

    n/a
    		 -0.15

    Debt / FCF

    n/a
    		 -0.26

    Interest Coverage

    n/a
    		 88.7

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-2,473,875

    Employee Count

    n/a
    		 8

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -41.1% in the last 52 weeks. The beta is 0.25, so Akari Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.25

    52-Week Price Change

    n/a
    		 -41.1%

    50-Day Moving Average

    n/a
    		 1.29

    200-Day Moving Average

    n/a
    		 1.76

    Relative Strength Index (RSI)

    n/a
    		 47.29

    Average Volume (20 Days)

    n/a
    		 24,084

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -21.64M

    Net Income

    n/a
    		 -19.79M

    EBITDA

    n/a
    		 -21.64M

    EBIT

    n/a
    		 -20.04M

    Earnings Per Share (EPS)

    n/a
    		 -160
    Full Income Statement

    Balance Sheet

    The company has 2.6M in cash and 3.26M in debt, giving a net cash position of -661K.

    Cash & Cash Equivalents

    n/a
    		 2.6M

    Total Debt

    n/a
    		 3.26M

    Net Cash

    n/a
    		 -661K

    Retained Earnings

    n/a
    		 -247.25M

    Total Assets

    n/a
    		 50.96M

    Working Capital

    n/a
    		 -17.56M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -12.55M and capital expenditures 0, giving a free cash flow of -12.55M.

    Operating Cash Flow

    n/a
    		 -12.55M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -12.55M

    FCF Per Share

    n/a
    		 -0.53
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    AKTX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for AKTX.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Aug 21, 2023. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Aug 21, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -8.45

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist